Laurion Capital Management’s Cascadian Therapeutics, Inc. CASC Stock Holding History

Laurion Capital Management’s Portfolio CASC Stock Details CASC Fund Activity

Upgrade to unlock

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell
2017 Q4	$965K	Buy
2016 Q3	–	Sell
2016 Q2	$258K	Buy